Integrative Tumor Board: Medical and Surgical Oncology Approach

Case Review In this case, we are presented with a 70-year-old male retired insurance executive, 35 pack-year smoker, with no other environmental exposure risks but with a history of lithotripsy for renal stones and with noninvasive papillary transitional cell carcinoma (TCC) in the right ureter and bladder (at least 2 sites). The patient presented with hematuria, right flank pain, urinary urgency, and dysuria. Bladder biopsy has been obtained, the right ureter has been stented, and imaging studies (computed tomography and bone scan) show right adrenal prominence and a questionable nodule in the bladder dome. Renal function studies are normal but with suggestion of right collecting system obstruction. Right total nephrectomy has initially been recommended.

[1]  Y. Kuroda,et al.  Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[2]  S. Johansson,et al.  Synchronous bilateral ureteral and renal pelvic carcinomas , 2004, Cancer.

[3]  R. Sylvester,et al.  A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. , 2004, The Journal of urology.

[4]  G. Hall,et al.  Systemic chemotherapy for patients with bladder cancer--current controversies and future directions. , 2004, Cancer treatment reviews.

[5]  A. Douvdevani,et al.  Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. , 2004, Urology.

[6]  E. Tuzel,et al.  Transitional cell carcinoma of the ureter and renal pelvis. , 2003, Critical reviews in oncology/hematology.

[7]  C. Sternberg,et al.  Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers. , 2003, Critical reviews in oncology/hematology.

[8]  E. Hungerhuber.  [Carcinomas of the upper urinary tract. With early diagnosis 80-100% of patients survive 5 years]. , 2003, MMW, Fortschritte der Medizin.

[9]  A. Folsom,et al.  Risk factors for urinary bladder carcinoma in postmenopausal women , 2002, Cancer.

[10]  D. Lamm,et al.  Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. , 2002, The Journal of urology.

[11]  D. Lamm.  Superficial bladder cancer , 2002, Current treatment options in oncology.

[12]  P. Adab,et al.  Does smoking status influence the prognosis of bladder cancer? A systematic review , 2002, BJU international.

[13]  C. Sternberg,et al.  New drugs and new approaches for the treatment of metastatic urothelial cancer , 2002, World Journal of Urology.

[14]  Marc Seltzer,et al.  Positron emission tomography in urologic oncology. , 2002, Cancer control : journal of the Moffitt Cancer Center.

[15]  D. Bostwick,et al.  Conserved genetic findings in metastatic bladder cancer: a possible utility of allelic loss of chromosomes 9p21 and 17p13 in diagnosis. , 2001, Archives of pathology & laboratory medicine.

[16]  D. Lamm,et al.  Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. , 2000, The Journal of urology.

[17]  James M. Kozlowski,et al.  NCCN Urothelial Cancer Practice Guidelines , 1998 .

[18]  G. Gerber,et al.  Endourological management of upper tract urothelial tumors. , 1993, The Journal of urology.

[19]  H. Pollack,et al.  Radiologic evaluation of the ureteral stump. , 1982, Radiology.

[20]  T. Kakizoe,et al.  Transitional cell carcinoma of the bladder in patients with renal pelvic and ureteral cancer. , 1980, The Journal of urology.

[21]  H. D. Pearse,et al.  Recurrent urothelial tumors following surgery for transitional cell carcinoma of the upper urinary tract , 1976, Cancer.

[22]  M. Zeegers,et al.  The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review , 2003, World Journal of Urology.

[23]  A Pollack,et al.  NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network. , 1998, Oncology.

[24]  J. Dehaven,et al.  Megadose vitamins in bladder cancer: a double-blind clinical trial. , 1994, The Journal of urology.

[25]  F. Algaba,et al.  Treatment of transitional cell carcinoma of the ureter: is the controversy justified? , 1990, European urology.